Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMF in Cutaneous T Cell Lymphoma
NCT02546440Phase 2Completed
- Sponsor
- Universitätsmedizin Mannheim
- Start
- Sep 2015
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dimethyl fumarate in cutaneous T-cell lymphoma (CTCL), sponsored by Universitätsmedizin Mannheim. Started Sep 2015; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT02546440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546440.